ConductScience.org, home

Paper42010708

Application of dendritic cell extracellular vesicles as a valid nanoparticle platform for cancer therapies: a narrative review.

Nezamdoust FV and 5 others. Stem Cell Res Ther, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Application of dendritic cell extracellular vesicles as a valid nanoparticle platform for cancer therapies: a narrative review. Papers, record 42010708. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42010708

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Application of dendritic cell extracellular vesicles as a valid nanoparticle platform for cancer therapies: a narrative review.
PubMed
Journal
Stem Cell Res Ther
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-10-03
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nezamdoust FVFereshteh Vaziri
2Nezhad-Mokhtari PParinaz
3Mirzaahmadi BBehnaz
4Mazloumi ZZeinab
5Kangari PParisa
6Rahbarghazi RReza

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Dendritic CellsMajor topic
Extracellular VesiclesMajor topic
NeoplasmsMajor topic
NanoparticlesMajor topic
ImmunotherapyMajor topic
Humans
Animals
Nanomedicine

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
73616Tabriz University of Medical SciencesPubMed

Source PubMed

Download CSV of grants

References146

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133437589Shedding Light on Extracellular Vesicle Biogenesis and Bioengineering.Adv Sci (Weinh)2020https://conductscience.org/library/papers/33437589PubMed
230991681A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials.Cancers (Basel)2019https://conductscience.org/library/papers/30991681PubMed
330848183Extracellular Vesicles as Drug Delivery Systems - Methods of Production and Potential Therapeutic Applications.Curr Pharm Des2019https://conductscience.org/library/papers/30848183PubMed
440571743Profound phenotypic deficiencies in mature blood and bone marrow progenitor dendritic cells in chronic lymphocytic leukemia patients.Leukemia2025https://conductscience.org/library/papers/40571743PubMed
531759432Dendritic cell extracellular vesicles.Int Rev Cell Mol Biol2019https://conductscience.org/library/papers/31759432PubMed
620138662Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles.Biomaterials2010https://conductscience.org/library/papers/20138662PubMed
735007784Exosome-mediated delivery of transforming growth factor-β receptor 1 kinase inhibitors and toll-like receptor 7/8 agonists for combination therapy of tumors.Acta Biomater2022https://conductscience.org/library/papers/35007784PubMed
838030790Functional evaluation of dendritic cells and extracellular vesicles as immunotherapy for breast cancer.Oncogene2024https://conductscience.org/library/papers/38030790PubMed
939592852Neoantigen-specific mRNA/DC vaccines for effective anticancer immunotherapy.Genes Immun2024https://conductscience.org/library/papers/39592852PubMed
1035629824Current Knowledge on Exosome Biogenesis, Cargo-Sorting Mechanism and Therapeutic Implications.Membranes (Basel)2022https://conductscience.org/library/papers/35629824PubMed
1138525778A Simple and Rapid Protocol for the Isolation of Murine Bone Marrow Suitable for the Differentiation of Dendritic Cells.Methods Protoc2024https://conductscience.org/library/papers/38525778PubMed
1232210954Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy.Front Immunol2020https://conductscience.org/library/papers/32210954PubMed
1340238941Efficient generation of human dendritic cells from induced pluripotent stem cell by introducing a feeder-free expansion step for hematopoietic progenitors.J Leukoc Biol2025https://conductscience.org/library/papers/40238941PubMed
1432440473Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer.Adv Sci (Weinh)2020https://conductscience.org/library/papers/32440473PubMed
1524566916Regulation of immune responses by extracellular vesicles.Nat Rev Immunol2014https://conductscience.org/library/papers/24566916PubMed
1635835409Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy.Cancer Lett2022https://conductscience.org/library/papers/35835409PubMed
1738172932Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review.J Nanobiotechnology2024https://conductscience.org/library/papers/38172932PubMed
1835090497Extracellular vesicle PD-L1 in reshaping tumor immune microenvironment: biological function and potential therapy strategies.Cell Commun Signal2022https://conductscience.org/library/papers/35090497PubMed
1932765522The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses.Front Immunol2020https://conductscience.org/library/papers/32765522PubMed
2034294165Exosomal delivery of therapeutic modulators through the blood-brain barrier; promise and pitfalls.Cell Biosci2021https://conductscience.org/library/papers/34294165PubMed

See all 146 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42560644Mitochondrial metabolism and PD-1 blockade: mechanisms and therapeutic opportunities in cancer immunotherapy.Mol Biol Rep2026https://conductscience.org/library/papers/42560644

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42010708

GET https://conductscience.org/api/papers/v1/42010708/references?page=2